Tech Transfer

PsiKick is utilizing revolutionary ultra-low-power technologies from the Universities of Virginia and Michigan to build completely self-powered sensing systems that do not require batteries, can be deployed nearly anywhere, and unlock new data stream

A WMRA podcast alludes to UVA's role in the biotechnology industry in Central Virginia.

Insulin delivery technology developed at UVA and commercialized by TypeZero Technologies, Inc. received initial support from UVA's Licensing and Ventures Group (LVG).

The UVA Licensing & Ventures Group (LVG) has invested in three Charlottesville-based ventures that grew out of University research. TypeZero Technologies Inc., TearSolutions Inc., and Mission Secure Inc.

A WMRA podcast alludes to UVA's role in the biotechnology industry in Central Virginia.

Mission Secure Inc. recently announced the closing of an $8 million Series A financing round led by Energy Innovation Capital and Chevron Technology Ventures.

Insulin delivery technology developed at UVA and commercialized by TypeZero Technologies, Inc. received initial support from UVA's Licensing and Ventures Group (LVG).

NSF funding will allow UVA Engineering’s Link Lab to develop a new program that will train graduate students to make discoveries and then translate that knowledge into new technologies, products and services.

The UVA Licensing & Ventures Group (LVG) has invested in three Charlottesville-based ventures that grew out of University research. TypeZero Technologies Inc., TearSolutions Inc., and Mission Secure Inc.

Professor Gregory B. Fairchild is the first director of Northern Virginia operations for the University of Virginia.

NSF funding will allow UVA Engineering’s Link Lab to develop a new program that will train graduate students to make discoveries and then translate that knowledge into new technologies, products and services.

Professor Gregory B. Fairchild is the first director of Northern Virginia operations for the University of Virginia.